Characteristics of the Tumor Microenvironment That Influence Immune Cell Functions: Hypoxia, Oxidative Stress, Metabolic Alterations

• Published in: Cancers Vol. 12; no. 12; p. 3802
• Main Authors: Augustin, Ryan C, Delgoffe, Greg M, Najjar, Yana G
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 17-12-2020; MDPI
• Subjects: Angiogenesis; Antigens; Biomarkers; Cancer therapies; Cytotoxicity; Genotype & phenotype; Hypoxia; Hypoxia-inducible factor 1; Immune checkpoint inhibitors; Immunosuppression; Immunotherapy; Infiltration; Ligands; Lipid metabolism; Lipid peroxidation; Lymphocytes; Lymphocytes T; Metabolism; Metabolites; Metastases; Oxidative stress; Pathophysiology; Phenotypes; Review; Transcription factors; Tumors; immunometabolism; cellular energetics; immunotherapy
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers12123802

Immunotherapy (IMT) is now a core component of cancer treatment, however, many patients do not respond to these novel therapies. Investigating the resistance mechanisms behind this differential response is now a critical area of research. Immune-based therapies, particularly immune checkpoint inhibitors (ICI), rely on a robust infiltration of T-cells into the tumor microenvironment (TME) for an effective response. While early efforts relied on quantifying tumor infiltrating lymphocytes (TIL) in the TME, characterizing the functional quality and degree of TIL exhaustion correlates more strongly with ICI response. Even with sufficient TME infiltration, immune cells face a harsh metabolic environment that can significantly impair effector function. These tumor-mediated metabolic perturbations include hypoxia, oxidative stress, and metabolites of cellular energetics. Primarily through HIF-1-dependent processes, hypoxia invokes an immunosuppressive phenotype via altered molecular markers, immune cell trafficking, and angiogenesis. Additionally, oxidative stress can promote lipid peroxidation, ER stress, and Treg dysfunction, all associated with immune dysregulation. Finally, the metabolic byproducts of lipids, amino acids, glucose, and cellular energetics are associated with immunosuppression and ICI resistance. This review will explore these biochemical pathways linked to immune cell dysfunction in the TME and highlight potential adjunctive therapies to be used alongside current IMT.